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ABSTRACT 
The only definitive diagnostic test for Malignant Hyperthermia, a 
genetic disease that effects skeletal muscle, is the 
caffeine-contracture test. Alternative tests are being sought since 
this test is not totally satisfactory. It requires muscle biopsy, an 
invasive procedure and often produces results difficult to interpret. 
A test that could be used for wide spread screening of all patients 
about to undergo an operation would reduce the incidence of unexpected 
Malignant Hyperthermic episodes induced by anaesthetics, the most 
common cause of an episode. 
In this project the effect of mild stress induction on skeletal 
muscle, ischaemia produced by a tourniquet is studied. The tourniquet 
effect on a sample of five pre-diagnosed Malignant Hyperthermia 
susceptible subjects is compared to the effect on a sample of twelve 
normal subjects. The effect was determined by the measurment of serum 
metabolites before and after tourniquet application. 
The variables measured were creatine kinase, lactate 
dehydrogenase, AMP deaminase, total solids, total protein, potassium, 
osmolality, inorganic 
pyrophosphatase. 
pyrophosphate, creatine and erythrocyte 
Between the two groups AMP-deaminase, creatine and osmolality 
showed no difference in response to tourniquet application. Inorganic 
pyrophosphate rose in the Malignant Hyperthermia group after tourniquet 
application but remained unaltered in the normal groups. All other 
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Malignant Hyperthermia variables moved in a negative direction with 
respect to the normal levels. That is if the normal metabolites level 
rose the Malignant hyperthermia metabolites stayed the same, or if the 
normal levels stayed the same the MH levels dropped. 
A measurement of resting metabolite levels showed Creatine kinase 
was higher in the MH subjects compared to the normal subjects levels 
but creatine and pyrophosphatase were lower in the MH subjects. These 
differences may form the basis of a diagnostic test. 
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1.1 Introduction 
Chapter 1 
INTRODUCTION 
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For those that have a genetically determined tendency to develop 
the condition of Malignant Hyperthermia(MH), any operation that 
involves general anaesthesia is a potentially fatal experience. 
Anaesthetics used on such a patient can trigger a series of metabolic 
events that leads to a rise in temperature that the body can not 
accommodate which results in death. 
At present,there is no diagnostic test for MH susceptibility 
available that is suitable for general screening of all patients about 
to undergo an operation. Because of this, unless a patient has an 
obvious family history of problems with anaesthesia or has previously 
survived a hyperthermic episode while being operated on it is unlikely 
that anyone could diagnose the susceptibility.It is therefore still 
common for surgeons to be taken by surprise by a patients adverse 
reaction to anaesthesia. 
What is required is an efficient and reliable diagnostic test for 
Malignant Hyperthermia Susceptibility (MHS) that can be given to all 
patients prior to surgery. 
In the lower half of the North island there is a family that 
carries the defective gene(s) that leads to MHS. Because of the 
proximity of the affected family to Massey this seemed an ideal 
opportunity to attempt to develope a diagnostic test for MHS that would 
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forewarn anaethesists to prepare for an attack of MH in susceptible 
subjects. 
1.2 HISTORY 
The first published report on MH (Denborough et al, 1970) spoke of 
accelerated metabolism due to anaesthesia. It resulted from an 
encounter with a young man who experienced MH while being operated on 
for a fractured leg. It was subsequently discovered that ten of this 
patients relatives had infact died as a direct result of ether 
anaesthesia. As a result of this report and many subsequent reports 
there grew a gradual awareness of the dangers of genetic susceptibility 
to certain anaesthetics and stress. 
et 
Awareness of a porcine form of MH developed from a report 
al, 1914) that described pork from pigs suffering 
hypermetabolic reaction as unsuitable for making sausage. 
(Ludvigsen, 1953) this was linked to an inherited 
(Herter 
from a 
In 1953 
muscular 
degeneration. The condition in pigs is termed Porcine Stress Syndrome 
(PSS) and has proven very useful in providing more information on the 
human condition with respect to the pathophysiology and identification 
of susceptible individuals. 
1.3 THE REACTION 
A reaction can occur in various degrees of severity ranging from 
mild fever and slight respiratory and metabolic acidosis to a major 
reaction that will eventually lead to death. 
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The earliest sign of an episode is an increased respiratory rate 
with rising carbon dioxide tension monitored by end tidal CO2 
analyzers. Respiration is deep and rapid in an attempt to clear the 
excess CO2. The next most consistent signs are unstable blood 
pressure, usually moving upwards and increased cardiac output with 
ventricular arrythmias. 
The most characteristic sign of an episode is muscle rigidity. 
When muscle rigidity occurs there is an acceleration of the metabolic 
rate and 02 consumption leading to the high CO2 and heat production 
previously described. 
Early in the reaction there is an increase in peripheral blood 
flow allowing for dissipation of heat but later peripheral 
vaso-constriction occurs shunting the blood away from the surface.At 
this stage the skin appears mottled. 
With insufficient supply of 02 to the muscle tissues there is an 
increase in peripheral anaerobic metabolism which results in lactic 
acid production. The lactic acid together with CO2 produces metabolic 
acidosis, especially of the venous blood. 
With increasing lactic acidosis the membrane becomes leaky leading 
to multiple electolyte abnormalities. Initially serum Ca++ levels rise 
but then fall as Ca++ is taken up by the muscle cells. Serum K+ levels 
rise as K+ leaks across damaged cell membranes as do serum phosphorous 
levels due to increased breakdown of ATP in the muscle.Severe swelling 
of the muscle can occur due to the large ion shifts and increased 
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permeability of the vasculature. Enzymes commonly found in muscle such 
as Creatine Kinase(CK), Lactic Dehydrogenase (LOH) and Glutamic 
oxaloacetic transaminase (GOT) also have been observed to be elevated, 
leaking over damaged membranes. CK tends to be highest about 24 hrs 
after an episode in surviving patients and has been reported to be as 
high as 100 000 International units(IU) in some cases, with 10 000 not 
uncommon. Normal levels in non-MHS people are 10->65 IU. 
Myoglobin from the breakdown in muscle tissue results in 
myoglobinaemia and then myoglobinuria causing red or brown colouring of 
the urine, followed by oliguria.Unless correctly treated this results 
in a reduction in renal function. 
The cause of death from an MH episode will vary according to the 
stage in the episode the death occurs . If death is one or two hours 
after onset of a reaction it will be due to high temperature,anoxia and 
arrythmia. Later death will be secondary to acute pulmonary oedema, 
and huge electrolyte and acid/base imbalances. 
A patient surviving 2 or 3 days may succumb to renal failure or 
brain damage from cerebral oedema and hypoxia, leading to 
decerebration. 
Patients who survive an acute episode with rigidity often complain 
of severe muscle pain for several days or weeks, the muscles being 
often swollen and tender. Electrolyte imbalances are common for 
several days after an episode. In bad cases the patients may be left 
with a neurological defecit evident in mental retardation or sight 
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loss. A few cases of a fatal recurrence of an episode several days 
after the initial episode have been reported so patients are carefully 
monitored for some time. 
It is pleasing to note the mortality rate of MH has fallen in 
recent years. Prior to 1970 the mortality rate was over 70 percent. 
In 1976 the reported rate was 28 percent and probably would be even 
lower today. 
A drug called Dantrolene has been found to be very effective in 
treatment of an episode and it no doubt has contributed largely to the 
decrease in the mortality rate. It apparently (Britt et al, 1984) 
increases Ca++ uptake into the sarcoplasmic reticulum (SR), preventing 
the dangerous situation of prolonged elevated myoplasmic Ca++ which 
appears to be associated with MH episodes. 
1.4 GENETICS 
Because of the repeated finding that the disease occurs in several 
members of any family and in successive generations it became obvious 
that MHS was a genetically inherited disease. In the 1960's two groups 
of workers (Britt et al, 1969 and Denborough et al, 1962) published 
large pedigrees of affected families which seemed to indicate MHS was 
inherited as an autosomal dominant trait. That is, it was not sex 
linked but only one gene of the pair needed to carry the defect for the 
condition to show. More recently however, evidence has been produced 
that suggests MHS inheritance is more complicated, possibly explaining 
the huge spectrum of severity and the variability of symptoms that 
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occurs in those with the disease. In some cases there is a pattern of 
less affected offspring than predicted by dominance patterns (called 
variable penetrance) and even where there is little variation within a 
family there are differing susceptibilities between families ( called 
variable expressivity). 
Since some people seem to suffer from a form of MHS that produces 
muscle rigidity during an attack and others do not it has been 
suggested there is a division of MH susceptibility into 
phenotypes.These may be inherited by more than one allele, making MHS a 
multifactorial genetic disorder with various degrees of 
susceptibilities. 
1.5 CAUSE OF DISEASE 
The exact defect that leads to susceptibility to MH has not been 
defined. The current theory is that there is a defect in the control 
mechanisms that maintain appropriate levels of intracellular Ca++. 
This has been vaguely described as due to an underlying membrane 
defect. 
Recent papers (Nibroj-Dobosoz et al, 1984 and Do Han Kim et al, 
1984 and Nelson , 1983) have looked at various specific components of 
the muscle membrane structure and most work has pointed to a defect in 
the channels that release Ca++ in the SR. 
Muscle contraction, is normally mediated by Ca++. A nerve impulse 
will be transmitted from the nerve then down transverse tubules causing 
Axon 
.,,.~ynaptic vesicles 
F JG 1.1 Ultrastructure of Motor end - pl ate on Muse le. 
---.._J 
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release of the Ca++ stored in the SR into the myoplasm. The 
Ca++ released acts as a trigger upon myofibrils lying beneath the 
transverse tubule- SR network resulting in an ATP dependent process 
involving various ion and protein interactions which causes contraction 
to occur. This is called excitation-contraction coupling. 
In MH muscle there seems to be some defect in the SR structure 
that leads to a much lower threshold for Ca++ release which ultimately 
produces a situation of elevated myoplasmic Ca++. 
Elevated Ca++ leads to increased ATP utilization by myosin ATPase 
and phosphorylase kinase. The resulting stimulation of glycolysis and 
Krebs cycle activity is responsible for the production of Lactic acid, 
CO2 and heat. Usually the SR would take up the excess Ca++ but in MH 
muscle this does not seem to occur so the contraction will be 
maintained until the membrane is damaged leading to leakage of K+, 
enzymes and myoglobin. Any excess Ca++ may be taken up by the 
mitochondria which results in the uncoupling of oxidative 
phosphorylation from the electron transport chain leading to decreased 
ATP production, accelerated oxygen consumption and output of lactic 
acid,carbon dioxide and heat. 
Catecholamines may also play a role. They may increase heat 
production by indirectly stimulating several metabolic processes such 
as gluconeogenesis, ureogenesis, triglyceride synthesis and glycogen 
synthesis. Their effect 
by radiation probably also 
of vasoconstriction which inhibits heat loss 
induces hyperthermia. These effects of 
catecholamines may explain stress involvement in inducing an episode. 
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Succinylcholine, one of the drugs used during the process of 
anaesthesia induction, is often implicated as a cause of MH induction 
during an operation. It has been found (McCullogh et al, 1982) that 
succinylcholine increases the release of ~atecholamines, specifically 
noradrenalin, which further supports the belief that catecholamines are 
involved in the MH syndrome. 
When all these events have taken place there is a rise in muscle 
temperature and decrease in muscle ATP and Creatine Phosphate(CP) which 
will perpetuate muscle rigor independently of the myoplasmic Ca++. ATP 
is required for muscle relaxation since it allows separation of the 
proteins, actin and myosin, responsible for contraction. Low ATP/ADP 
ratios are a metabolic stimulus leading to heat production.ATP also 
controls insulin binding to the cells which controls hyperkalemia so K+ 
control is lowered. ATP is also needed by the SR for the operation of 
the calcium pumps so since the ATPases are not working the ions will 
follow their concentration gradient where K+, Mg+, phosphate and 
enzymes and myoglobin leak out. Ca++ will simultaneously leak in and 
further disrupt the system. 
1.6 TRIGGERING AGENTS 
Nearly all potent inhalation anaesthetics and muscle relaxants 
have been implicated as triggering agents of MH episodes. 
Halothane and succinylcholine are the most commonly known triggers 
but methoxyflurane, diethylether, cyclopropane, ethylene, 
decamethomium, gallamine and mepivacaine have also been implicated. 
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In pigs, large intravenous caffeine doses can trigger a reaction 
and some MH people are known to react badly to coffee. 
Sympathomimetrics and parasympatholytics will aggravate an already 
established reaction. Since many anaesthetic agents are used in 
combination the direct cause of an episode will often be unclear and in 
some cases it is believed that surgical stress will contribute to the 
onset of a reaction. 
With swine in certain situations where anaesthetics have not been 
used, MH reactions have been known to occur. For example stress such 
as exercise, breeding, heat, anoxia apprehension or excitement can be a 
trigger. In humans, triggering of an episode without anaesthetics has 
not been proven but susceptible families definitely have a high rate of 
unexplained deaths. Emotional stress, prolonged exercise or excessive 
skeletal muscle injury, severe shivering or situations of apprehension 
have been suggested as non-anaesthetic triggers in humans. The 
exposure of muscle to excess norepinephrine is believed to be the 
underlying cause of the stress related reactions. 
1.7 0CCURENCE 
MH is best known in humans and pigs but has variously been 
reported to occur in cattle, greyhounds, racehorses and giraffes. 
The condition is rare in humans,reported to occur about 1 in 15000 
(Britt et al, 1970) although the true incidence is believed to be much 
higher. Those most susceptible seem to be between the ages of 3 and 
30. Above that the incidence gradually declines with no cases being 
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reported in the over 78 age group. Episodes seem to be more common in 
teenage males than females but this is believed to be because of the 
higher admittance of male trauma cases into the operating theatres. 
When these cases are removed from the statistics the incidence of MH is 
equally common in both sexes. 
About 50 percent of those experiencing an episode have previously 
undergone anaesthesia with no obvious reaction.The record (Britt et al, 
1977 and Britt, 1977) is 12 anaesthesias involving triggering drugs 
with no effects before a fatal 13th. 
All racial groups are effected, but reports from various areas 
have not been studied closely enough to determine if there are any 
racial or climatic differences. 
1.8 DIAGNOSTIC TESTS 
Serum Creatine Kinase(CK) is commonly used as a rough screening 
test for MHS. 
CK has generally been found to be high in MH patients but the 
usefulness of this finding is limited as some that are known to have MH 
have normal CK levels. Also several diseases unrelated to MHS feature 
elevated CK levels. 
The CK test has been evaluated in terms of efficiency, sensitivity 
and specificity (Anaranath et al, 1985). Sensitivity is the frequency 
of the true positive finding when the individual screened is known to 
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have MHS. Specificity is the frequency of the true negative findings 
when the individual screened does not have MHS. An efficient test will 
establish either the presence or absence of MHS in every individual 
screened. 
The CK test has been found to be efficient; nevertheless, in one 
study for every positive result there was 100 false-positive results. 
The predictive value for the negative test is good but does not 
compensate for the patients who are MH but have normal CK values. A 
low specificity would be acceptable if the sensitivity was around 100 
percent but this was not found to be the case. 
In 1970 (Kalow et al, 1970 and Kalow et al, 1977) an assay was 
developed that screened for MHS by testing the effect of caffeine on 
skeletal muscle. The test requires biopsy of skeletal muscle, usually 
that of the quadricep muscle.The muscle is immersed in Ringer in a 
water bath. One end is tied by silk thread to an electrode which is 
also immersed in Ringer and the other end tied to a force displacement 
transducer that records the resulting contracture when certain stimuli 
are applied to the muscle. After allowing the muscle to stabilize, a 
tension is applied to the muscle and it is stimulated at regular 
intervals by electrodes connected to a generator. 
The muscle is exposed to a series of concentrations of caffeine 
beginning at about 2mM and then doubling in sequence, to find the 
concentration that causes contracture tensions above and below a set 
value. Once the caffeine measurements are done the muscle is exposed 
to halothane and the various concentrations of caffeine are applied 
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again to study the potentiating effects of halothane. The measured 
parameter is the distance of the recording above the line representing 
the resting tension.From calibration curves the distance can be 
converted to grams of tension increase to a given concentration of 
caffeine. Using graphical means the caffeine concentration which 
causes an increase of lg tension is determined. 
Although this is the best diagnostic test available at present it 
has several features that prevent it from being ideal. 
1. The biopsy procedure requires patients to be in hospital 
for two days. For some patients it is a traumatic experience 
and may leave a permanent scar on the thigh. 
2. The execution of the test itself is not easy and requires 
carefully trained and experienced operators.Muscle tissue can 
easily be damaged and rendered unresponsive in the process of 
mounting the muscle in the water bath. 
3. Interpretation of the results does not necessarily produce 
definitive positive or negative cases.That is, the efficiency 
is not 100 percent. 
Because of these problems many researchers are trying to find a 
more appropriate test. The options explored have been diverse. Some 
of the main areas studied are as follows: 
1. An attempt to find an unusual isoenzyme patterm of CK 
in MHS muscle has been sought by several groups but no 
consistent pattern has been uncovered. (Sigmond et al, 1977 
and Hassan et al, 1977) 
2. Because of the belief that MH syndrome is due to an 
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intrinsic defect in muscle membranes, particularly of 
the sarcoplasmic reticulum, attempts have 
been made to identify unusual membrane proteins by 
electrophoretic techniques. 
(Shirooky et al, 1983; Blanck et al, 1984; Fletcher et al, 
1984; Fletcher et al, 1985; Marjanen et al, 1986 and 
Walsh et al, 1986) 
3. Some believed HLA typing would identify MH susceptibility 
(Hutsky et al, 1982) however no such connection was found. 
4. Several groups suggested that there was a positive 
correlation between pyrophosphate and creatine kinase levels. 
Measurement of pyrophosphate was offered as an alternative 
and additional screening test to CK measurements. 
(Van Wormer et al, 1977; Tan et al, 1977) 
5. One group found adenylate kinase to be deficient in 
MHS subjects. 
(Schmidt et al, 1977) however later studies by another 
group failed to confirm this.(Marjanen et al, 1982) 
6. Adenylate cyclase and cAMP of MHS skeletal muscle 
is reported to be abnormally high. (Willner et al, 1981) 
7. Morphological studies of MHS skeletal muscle showed 
numerous and enlarged mitochondria, more lysozymes and 
myelin like bodies. (Hull et al, 1978) 
8. Motor unit counting was offered as an alternative 
to the caffeine-contracture test. It was found to be less 
accurate but had the advantage of being less invasive. 
(Britt et al, 1977) 
9. An unusually high regional oxygen consumption was 
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recorded when a tourniquet was applied to an upper arm 
for ten minutes. (Roberts et al, 1982) 
10. In several patients already diagnosed as MHS patients, 
myoadenylate deaminase was found to be deficient. 
(Fishbein et al, 1985) 
11. Considerable attention has been given to the 
frequency of the fluoride resistant cholinesterase 
variants in patients with MHS. Some groups 
(Evans et al, 1981 and Ellis et al, 1978) have found 
a high frequency while other workers (Ording et al, 1981) 
found no such abnormality. 
12. Considerable work has also been directed at 
abnormal erythrocyte fragility and abnormal platelet 
aggregation in MHS subjects, (Alerner et al, 1977). 
Use of a platelet nucleotide assay as a test for MHS has 
been given appreciable attention (Lu et al, 1985). 
Unusual platelet metabolism has also been studied 
(Solomans et al, 1977). 
1.9 MUSCLE STRESS EFFECT ON NORMAL SUBJECTS 
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The present project was designed about the possibility that MHS 
muscle may be abnormally leaky when subjected to stress. Several 
studies (Haggmark et al, 1981 and Karlsson et al, 1981 and Larsson et 
al, 1978) have been performed on normal populations looking at the 
effect of muscle stress on muscle and blood constituents. 
One study (Karlsson et al, 1981) looked at muscle ATP, creatine 
phosphate (CP), glycogen and lactate levels after 30 and 60 minutes of 
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exercise. Muscle tissue was obtained by needle biopsy. The metabolite 
changes seen were an increase in muscle glycogen and lactate, a 
decrease in CP and no change in ATP levels. The CP and ATP response 
was explained by an apparent lack of oxygen availability required to 
facilitate resynthesis of both CP and ATP. The maintenance of ATP 
levels was believed to be at the expense of the CP. Lactate built up 
in the muscle tissue but measurement of blood lactate showed no change 
during the exercise. It was proposed the blood lactate level did not 
change due to the capacity of other tissues to take up and utilise any 
lactate produced in the muscle cell. This is essential to prevent 
tissue damage during exercise. 
Similar studies of the effect of muscle stress in the form of 
tourniquet application were performed to determine the response of 
electrolytes (Larsson et al, 1978) and metabolites (Haggmark et al, 
1981). 
In the study of electrolyte response tourniquets were applied for 
about two hours to the upper part of the thigh. Muscle was sampled by 
using the punch biopsy needle method and analysed for Na, K+, Mg++ and 
Cl-. The blood was analysed for osmolality, Na+ and K+. After 
tourniquet release there was a considerable rise in blood flow that did 
not return to normal until 15 minutes had elapsed. K+ levels were 
found to be elevated after tourniquet release and continued to be 
elevated for some time. No correlation was found between K+ levels and 
the duration of occlusion. Na+ showed a small increase in levels after 
tourniquet release. 
tourniquet release. 
Osmolality also rose significantly after 
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In the muscle, total Cl- rose after tourniquet release but K+, 
Mg++ and Na+ showed no significant change. It was suggested the K+ 
increase in the blood was involved in the increased blood flow as K+ 
has a vasodilator effect in skeletal muscle. Acidosis 
influence K+ levels causing an increase in extracellular 
may 
levels 
also 
and 
decrease in intracellular levels. The osmolality changes may be due to 
release of vasoactive agents involved in the hemodynamic response. 
Release of lactate, and possibly glucose may also contribute to the 
increase in osmolality. 
In the second paper tourniquets were applied for 60 to 120 minutes 
and muscle biopsies taken every 15 minutes during the course of the 
ischemia. Muscles were analysed for lactate, ATP and CP. During the 
course of the ischemia ATP remained unchanged, lactate gradually rose 
and CP fell. After tourniquet release ATP still showed little change 
but lactate fell and CP rose back to pre-tourniquet levels. 
These studies used prolonged periods of tourniquet application 
that are not possible on MHS subjects as no anaesthetic can be used. 
Nevertheless some of the changes observed such as the K+ rise were not 
dependent on duration of occlusion and therefore probably would also 
occur after much shorter periods of ischemia. 
Since tourniquet application causes detectable changes in 
metabolite levels in the blood of normal, healthy tissue, changes may 
also be seen in MHS tissue. Since the MH syndrome is believed to 
involve structural abnormalaties in the muscle, particularly of cell 
membranes, these abnormalaties may be reflected in the response to 
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tourniquet application. Tourniquet application is a particularly 
appropriate method of stress induction on MHS muscle as it produces 
ischemia which results in anaerobic metabolism which is what occurs 
during an MH episode. Tourniquet application is therefore simulating 
an MH episode and may produce similar metabolite changes. Comparison 
of the metabolite responses of normal tissue to MHS tissue after 
tourniquet application may reveal differences that could form the basis 
of a diagnostic test. 
this possibility. 
This project has been designed to investigate 
